Akoya Biosciences, Inc. (AKYA)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Akoya Biosciences, Inc. (AKYA)
Company Performance

Current Price

as of Oct 18, 2024

$3.14

P/E Ratio

N/A

Market Cap

$155.43M

Description

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.

Metrics

Overview

  • HQMarlborough, MA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerAKYA
  • Price$3.14+2.61%

Trading Information

  • Market Cap$155.43M
  • Float44.68%
  • Average Daily Volume (1m)134,619
  • Average Daily Volume (3m)155,556
  • EPS-$1.23

Company

  • Revenue$93.22M
  • Rev Growth (1yr)-1.52%
  • Net Income-$13.15M
  • Gross Margin57.79%
  • EBITDA Margin-39.16%
  • EBITDA-$9.07M
  • EV$155.12M
  • EV/Revenue1.66
  • P/EN/A
  • P/S1.66
  • P/B6.98